SG11201912883WA - Nucleic acid ratio determination - Google Patents
Nucleic acid ratio determinationInfo
- Publication number
- SG11201912883WA SG11201912883WA SG11201912883WA SG11201912883WA SG11201912883WA SG 11201912883W A SG11201912883W A SG 11201912883WA SG 11201912883W A SG11201912883W A SG 11201912883WA SG 11201912883W A SG11201912883W A SG 11201912883WA SG 11201912883W A SG11201912883W A SG 11201912883WA
- Authority
- SG
- Singapore
- Prior art keywords
- nucleic acid
- acid ratio
- ratio determination
- determination
- nucleic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Theoretical Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Pathology (AREA)
- Evolutionary Computation (AREA)
- Toxicology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Software Systems (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017905138A AU2017905138A0 (en) | 2017-12-21 | Nucleic acid ratio determination | |
| PCT/AU2018/051406 WO2019119072A1 (en) | 2017-12-21 | 2018-12-21 | Nucleic acid ratio determination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201912883WA true SG11201912883WA (en) | 2020-01-30 |
Family
ID=66992472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201912883WA SG11201912883WA (en) | 2017-12-21 | 2018-12-21 | Nucleic acid ratio determination |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12123051B2 (en) |
| EP (1) | EP3685385A4 (en) |
| JP (1) | JP7355652B2 (en) |
| KR (1) | KR102862383B1 (en) |
| CN (1) | CN111492434B (en) |
| AU (1) | AU2018390995B2 (en) |
| BR (1) | BR112020000845A2 (en) |
| CA (1) | CA3066287A1 (en) |
| IL (1) | IL271510B2 (en) |
| MX (1) | MX2020006590A (en) |
| SG (1) | SG11201912883WA (en) |
| WO (1) | WO2019119072A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115786549A (en) * | 2022-10-31 | 2023-03-14 | 宁波大学 | Primer and probe sequence for detecting tigecycline drug-resistant gene tet (X) RPA and application thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258543B1 (en) * | 1996-05-02 | 2001-07-10 | Xtrana, Inc. | Quantitation of RNA transcripts using genomic DNA as the internal amplification competitor |
| EP0910666B1 (en) * | 1996-05-02 | 2006-08-09 | Applera Corporation | Quantitation of rna transcripts using genomic dna as the internal amplification competitor |
| EP1627061B1 (en) * | 2001-05-18 | 2009-08-12 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| EP1418241A1 (en) * | 2002-11-08 | 2004-05-12 | PrimaGen Holding B.V. | Method for quantifying a ratio between at least two nucleic acid sequences |
| DK1948822T3 (en) | 2005-10-07 | 2011-10-17 | Johnson & Johnson Res Pty Ltd | Multicomponent nucleic acid enzymes and methods for their use |
| BRPI0718137B1 (en) | 2006-10-06 | 2016-05-10 | Johnson & Johnson Res Pty Ltd | molecular switches and methods for their use |
| CN101802216B (en) | 2007-04-05 | 2014-12-10 | 斯比戴克斯私人有限公司 | Nucleases and complexes and methods of use thereof |
| US8021846B2 (en) * | 2008-03-12 | 2011-09-20 | Medical Diagnostic Laboratories, Llc | Method for determining azole resistance in Candida glabrata |
| US8426133B2 (en) * | 2009-05-26 | 2013-04-23 | Quest Diagnostics Investments Incorporated | Methods for detecting gene dysregulation by intragenic differential expression |
| EP2280081A1 (en) * | 2009-07-31 | 2011-02-02 | Qiagen GmbH | Method of normalized quantification of RNA |
| WO2011109901A1 (en) * | 2010-03-10 | 2011-09-15 | The Governors Of The University Of Alberta | Detection and quantification of viable bacteria in a sample using rpos mrna |
| WO2011140237A2 (en) * | 2010-05-04 | 2011-11-10 | The Government Of The Usa Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Process for detection of multidrug resistant tuberculosis using real-time pcr and high resolution melt analysis |
| EP2721173A1 (en) * | 2011-06-14 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals |
| US9694049B2 (en) * | 2011-08-11 | 2017-07-04 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The Unitversity Of Nevada, Reno | Methods for treating muscular dystrophy |
| US20180087113A1 (en) * | 2016-09-27 | 2018-03-29 | Oncology Venture ApS | Methods for predicting drug responsiveness in cancer patients |
-
2018
- 2018-12-21 IL IL271510A patent/IL271510B2/en unknown
- 2018-12-21 CA CA3066287A patent/CA3066287A1/en active Pending
- 2018-12-21 BR BR112020000845-1A patent/BR112020000845A2/en unknown
- 2018-12-21 SG SG11201912883WA patent/SG11201912883WA/en unknown
- 2018-12-21 KR KR1020197038255A patent/KR102862383B1/en active Active
- 2018-12-21 EP EP18891196.0A patent/EP3685385A4/en active Pending
- 2018-12-21 WO PCT/AU2018/051406 patent/WO2019119072A1/en not_active Ceased
- 2018-12-21 MX MX2020006590A patent/MX2020006590A/en unknown
- 2018-12-21 AU AU2018390995A patent/AU2018390995B2/en active Active
- 2018-12-21 CN CN201880043163.4A patent/CN111492434B/en active Active
- 2018-12-21 US US16/619,932 patent/US12123051B2/en active Active
- 2018-12-21 JP JP2019566887A patent/JP7355652B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3685385A4 (en) | 2021-09-22 |
| CA3066287A1 (en) | 2019-06-27 |
| US12123051B2 (en) | 2024-10-22 |
| KR20200101269A (en) | 2020-08-27 |
| CN111492434B (en) | 2024-04-19 |
| MX2020006590A (en) | 2020-09-09 |
| WO2019119072A1 (en) | 2019-06-27 |
| NZ759676A (en) | 2025-05-02 |
| CN111492434A (en) | 2020-08-04 |
| JP2021507674A (en) | 2021-02-25 |
| US20200199651A1 (en) | 2020-06-25 |
| RU2020102949A (en) | 2022-01-21 |
| BR112020000845A2 (en) | 2020-07-21 |
| AU2018390995A1 (en) | 2019-12-19 |
| IL271510B1 (en) | 2025-03-01 |
| AU2018390995B2 (en) | 2023-11-23 |
| IL271510A (en) | 2020-02-27 |
| KR102862383B1 (en) | 2025-09-18 |
| JP7355652B2 (en) | 2023-10-03 |
| IL271510B2 (en) | 2025-07-01 |
| EP3685385A1 (en) | 2020-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278000B (en) | Synthetic nucleic acid spike-ins | |
| IL254000A0 (en) | Nucleic acid sequence assembly | |
| EP3472359A4 (en) | Nucleic acid sequencing | |
| GB201507119D0 (en) | Nucleic Acid Construct | |
| GB201507115D0 (en) | Nucleic Acid Construct | |
| GB201507111D0 (en) | Nucleic acid construct | |
| GB201507104D0 (en) | Nucleic acid construct | |
| GB201507108D0 (en) | Nucleic acid construct | |
| SG11201802138TA (en) | Antisense nucleic acid | |
| GB201403216D0 (en) | Nucleic acid sample preparation | |
| IL263423A (en) | Aptamer-based analyte assays | |
| GB201511969D0 (en) | Biosensor | |
| GB201413318D0 (en) | Nucleic acid sample preparation | |
| GB201805223D0 (en) | Nucleic acid amplification | |
| GB201812474D0 (en) | Nucleic acid construct | |
| GB201517241D0 (en) | DNA modification | |
| GB201506669D0 (en) | Nucleic acid sample enrichment | |
| GB201517458D0 (en) | Assay | |
| GB201415674D0 (en) | Nucleic acid analysis | |
| SG11202004757RA (en) | Dna polymerases | |
| IL271510A (en) | Nucleic acid ratio determination | |
| GB2553907B (en) | Nucleic acid analyzer | |
| GB201511725D0 (en) | Assay | |
| AU2017905138A0 (en) | Nucleic acid ratio determination | |
| GB201613839D0 (en) | Novel nucleic acid construct |